We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$3.11M
2
XOM icon
ExxonMobil
XOM
+$2.53M
3
IMGN
Immunogen Inc
IMGN
+$2.22M
4
CVX icon
Chevron
CVX
+$2.06M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.23M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COR icon
526
Cencora
COR
$60.3B
$481K 0.03%
2,500
+64
+3% +$11.1K
LVS icon
527
Las Vegas Sands
LVS
$30.5B
$480K 0.03%
8,268
+2,745
+50% +$162K
PHG icon
528
Philips
PHG
$25.4B
$479K 0.03%
24,707
-6,042
-20% -$106K
NGG icon
529
National Grid
NGG
$82.7B
$479K 0.03%
7,546
-1,444
-16% -$94.7K
ING icon
530
ING
ING
$93.8B
$476K 0.03%
35,360
-6,766
-16% -$86.5K
CCL icon
531
Carnival Corporation Ltd
CCL
$36.1B
$476K 0.03%
25,276
+8,436
+50% +$98.7K
KGC icon
532
Kinross Gold
KGC
$28.5B
$471K 0.03%
98,828
+120
+0.1% +$599
RVNC
533
DELISTED
Revance Therapeutics, Inc.
RVNC
$471K 0.03%
18,606
+1,585
+9% +$49.4K
NI icon
534
NiSource
NI
$22.4B
$470K 0.03%
17,194
-1,255
-7% -$34.8K
CDW icon
535
CDW
CDW
$17.1B
$470K 0.03%
2,560
+660
+35% +$115K
OII icon
536
Oceaneering
OII
$5.25B
$470K 0.03%
25,120
-6,430
-20% -$111K
ZBH icon
537
Zimmer Biomet
ZBH
$17.7B
$468K 0.03%
3,217
+60
+2% +$8.15K
BTI icon
538
British American Tobacco
BTI
$132B
$466K 0.03%
14,029
-2,685
-16% -$91.8K
SLAB icon
539
Silicon Laboratories
SLAB
$7.15B
$464K 0.02%
2,939
+58
+2% +$8.76K
CRNX icon
540
Crinetics Pharmaceuticals
CRNX
$8.86B
$461K 0.02%
25,596
+1,193
+5% +$23.8K
SBSW icon
541
Sibanye-Stillwater
SBSW
$5.92B
$455K 0.02%
72,960
+2,239
+3% +$17.7K
MTD icon
542
Mettler-Toledo International
MTD
$26.8B
$455K 0.02%
347
+8
+2% +$11.2K
OLED icon
543
Universal Display
OLED
$3.71B
$453K 0.02%
3,143
+61
+2% +$8.74K
COGT icon
544
Cogent Biosciences
COGT
$6.79B
$450K 0.02%
37,987
-7,275
-16% -$83.5K
GGG icon
545
Graco
GGG
$12.9B
$450K 0.02%
5,207
-669
-11% -$52K
MSCI icon
546
MSCI
MSCI
$40B
$449K 0.02%
957
-17
-2% -$8.29K
AFL icon
547
Aflac
AFL
$63.9B
$448K 0.02%
6,412
-235
-4% -$15.7K
RXRX icon
548
Recursion Pharmaceuticals
RXRX
$1.57B
$445K 0.02%
59,614
-11,610
-16% -$81.2K
AME icon
549
Ametek
AME
$55.5B
$444K 0.02%
2,740
+230
+9% +$33.6K
MKSI icon
550
MKS Inc
MKSI
$22.2B
$443K 0.02%
4,098
-16
-0.4% -$1.47K
20 21
22
23 24

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.